Bone is a common site of metastatic spread in patients with advanced renal cell carcinoma (RCC) occurring in around one-third of patients enrolled in clinical trials evaluating modern systemic therapies for this disease. Until recently. limited systemic therapeutic options were available for advanced RCC. Nowadays. https://www.truvisionhealthftp.com/